Validation of a Microbiological Method Using Acholeplasma laidlawii for Assessing Performance of Microporous Membranes for Mycoplasma Clearance

References

1. ↵
   1. Razin S.,
   2. Yogev D.,
   3. Naot Y.

   Molecular biology and pathogenicity of mycoplasmas. Microbiology and Molecular Biology Reviews 1998, 62 (4), 1094–1156.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Bates S.,
   2. Nguyen N,
   3. Roche Lentine K.

   Development of serum-free media for the cultivation and recovery of Acholeplasma laidlawii used for challenge testing sterilizing-grade filters used in biopharmaceutical applications. PDA J. Pharm. Sci. Technol. 2008, 62 (6), 402–420.

   OpenUrlAbstract/FREE Full Text
3. ↵
   1. Low I.

   Isolation of Acholeplasma laidlawii from commercial, serum-free tissue culture medium and studies on its survival and detection. Appl. Microbiol. 1974, 27 (6), 1046–1052.

   OpenUrlPubMed
4. ↵
   1. Uratani B.

   A firm has multiple media fill failures questions and answers on current good manufacturing practices, good guidance practices, level 2 guidance control of components and drug product containers and closures. FDA Center for Drug Evaluation and Research. http://www.fda.gov/CDER/guidance/cGMPs/component.htm#3. 2004.
5. ↵
   United States Pharmacopeia. 〈1211〉 Sterilization and Sterility Assurance of Compendial Articles. United States Pharmacopeial Convention: Rockville, MD, 2006.
6. ↵
   Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Office of Regulatory Affairs. Guideline on sterile drug products produced by aseptic processing. Food and Drug Administration: Rockville, MD, 2004.
7. ↵
   International Organization for Standardization. Aseptic Processing of Health Care Products—Part 2: Filtration. ISO 13408-2:2003(E). ISO Copyright Office, Geneva, Switzerland. 2003.
8. ↵
   Parenteral Drug Association. Sterilizing filtration of liquids. PDA technical report no. 26. J. Pharm Science and Tech. 1998, 52 (3), Supplement 1.
9. ↵
   1. Bower J.

   Correlation of biologic retention, latex particle retention and physical tests on 0.1 micron pore rated membrane filters. ASTM Special Technical Publication 975; ASTM International: West Conshohocken, PA (formerly ASTM: Philadelphia, PA), 1985, pp 51–58.
10. ↵
    Domnick Hunter Limited. Bacterial Challenge & Correlation to Integrity Test Data for Sterilising Grade Pharmaceutical Air & Liquid Filters. Domnick Hunter Limited. Publication Reference PD00/11/02. 2002.
11. ↵
    1. Janas J.

    Verifying membrane filter-based bacterial removal using titer reduction. Med Device & Diagnostic Industry 1999, 21 (7), 81–82.

    OpenUrl
12. ↵
    1. Meeker J. T.,
    2. Hickey E. W.,
    3. Martin J. M.,
    4. Howard G., Jr.

    Technical Note: a quantitative method for challenging 0.1 μm rated filters with A. laidlawii. BioPharm. 1988, 5 (3), 41.

    OpenUrl
13. ↵
    1. Roche K. L.,
    2. Levy R. V.

    Methods used to validate microporous membranes for the removal of mycoplasma. Biopharm 1992, 5 (3), 22–33.

    OpenUrl
14. ↵
    1. Sartorius AG.

    Validation Guide Sartopore 2 0.1 μm Cartridges. Sartorius AG, Goettingen, Germany. Publication No. SPK 5735-e 00041. Undated, 22–24.
15. ↵
    1. Sundaram S.,
    2. Eisenhuth J.,
    3. Lewis M.,
    4. Howard G, Jr.,
    5. Brandwein H.

    Method for qualifying microbial removal performance of 0.1 micron rated filters part III: bacterial challenge tests on 0.2/0.22 and 0.1 micron rated filter cartridges with Hydrogenophaga (formerly Pseudomonas) pseudoflava. PDA J. Pharm. Sci. Technol. 2001, 55 (6), 393–416.

    OpenUrlAbstract/FREE Full Text
16. ↵
    1. Waibel P. J.,
    2. Wolber P.

    Validation of 0.1 μm retentive membranes. Focal Points 1989, 1 (3). Sartorius Corporation, Bohemia, NY.
17. ↵
    1. Drexler H. G.,
    2. Uphoff C. C.

    Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology 2002. 39 (2), 75–90.

    OpenUrlCrossRefPubMed
18. ↵
    American Society for Testing and Materials. Standard test method for determining bacterial challenge of membrane filters utilized for liquid filtration. ASTM F838-05. ASTM International: West Conshohocken, PA. 2005.
19. ↵
    Parenteral Drug Association. Evaluation, validation and implementation of new microbiological testing methods. PDA technical report no. 33. PDA J. Pharm. Sci. Technol 2000, 54 (3), 1–35.

    OpenUrl
20. ↵
    United States Pharmacopeia. 〈1223〉 Validation of alternative microbiological methods. United States Pharmacopeial Convention: Rockville, MD. 2006.
21. ↵
    United States Pharmacopeia. 〈1225〉 Validation of compendial procedures. United States Pharmacopeial Convention: Rockville, MD. 2006.
22. International Conference on Harmonisation. ICH Harmonised Tripartite Guideline Validation of Analytical Procedures: Text and Methodology. ICH Q2 (R1). 2005.
23. ↵
    American Public Health Association. Standard Methods for the Examination of Water and Wastewater, 21st ed.; Part 9215; American Public Health Association: Washington DC, 2005.
24. ↵
    United States Pharmacopeia. 〈1227〉 Validation of microbial recovery from pharmacopeial articles. United States Pharmacopeial Convention: Rockville, MD. 2006.
25. ↵
    1. Carter J.

    Evaluation of recovery filters for use in bacterial retention testing of sterilizing-grade filters. PDA J. Pharm. Sci. Technol. 1996, 50 (3), 147–153.

    OpenUrlAbstract/FREE Full Text